|

Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer

RECRUITINGN/ASponsored by The First Affiliated Hospital with Nanjing Medical University
Actively Recruiting
PhaseN/A
SponsorThe First Affiliated Hospital with Nanjing Medical University
Started2024-07-01
Est. completion2025-09
Eligibility
Age18 Years – 75 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07092111

Summary

Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Eligibility

Age: 18 Years – 75 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Patients with breast cancer diagnosed with stage I-III;
* Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months;
* 18 years old≤ age≤ 75 years old, female;
* Subjects voluntarily participate in this trial and sign the informed consent form.

Exclusion Criteria:

* Patients who have had acupuncture treatment in the past;
* After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture.
* Platelets\< 50,000/μL;
* Patients with CIPN≥1 grade 1 (NCI-CTCAE);
* Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.

Conditions3

Breast CancerCancerChemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.